Literature DB >> 11060875

Heart rhythm during syncope and presyncope: results of implantable loop recorders.

P R Nierop1, R van Mechelen, A van Elsäcker, R H Luijten, A Elhendy.   

Abstract

Ambulatory ECG monitoring in patients with recurrent syncope is nondiagnostic in the majority of cases. Recently, an ECG implantable loop recorder (ILR) has been introduced. The ILR performs continuous ECG monitoring over a period of at least 14 months. From February 1997 to September 1999, 35 patients underwent implantation of an ILR. During a mean follow-up of 11 +/- 8 months, 24 (69%) patients had recurrent syncope or presyncope events. Four (11%) patients were not capable of activating the ILR to save the event. A symptom-rhythm correlation could be studied in 20 (83%) of 24 patients. Forty of 44 recurrences were captured by the ILR. There were 14 (40%) patients with at least one syncopal episode. An arrhythmic cause for syncope was found in eight of them (bradycardia in four and tachycardia in four). In the other six patients the heart rhythm was normal. In 17 (49%) patients with 1-year follow-up, the mean syncope event rate 12 months before ILR implantation was 4.7 +/- 2.4, whereas the mean syncope event rate 12 months after ILR implantation was 1.3 +/- 0.7 (P < 0.01). Resolution of symptoms was observed in 6 (17%) patients. These patients were significantly younger than patients without resolution (50 +/- 18 vs 69 +/- 14 years, p < 0.01) and five were women. Three (9%) patients died during follow-up, all of them were noncompliant during their follow-up. In conclusion, the ILR made symptom-rhythm correlation possible in 83% of patients with recurrent syncope. Syncope recurrences decreased significantly after implantation of the device, especially in the younger patients. Noncompliant patients had a high mortality rate.

Entities:  

Mesh:

Year:  2000        PMID: 11060875     DOI: 10.1046/j.1460-9592.2000.01532.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

Review 1.  Evaluation of syncope.

Authors:  M Yousuf Kanjwal; Blair P Grubb
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

2.  Guidelines for the diagnosis and management of syncope (version 2009).

Authors:  Angel Moya; Richard Sutton; Fabrizio Ammirati; Jean-Jacques Blanc; Michele Brignole; Johannes B Dahm; Jean-Claude Deharo; Jacek Gajek; Knut Gjesdal; Andrew Krahn; Martial Massin; Mauro Pepi; Thomas Pezawas; Ricardo Ruiz Granell; Francois Sarasin; Andrea Ungar; J Gert van Dijk; Edmond P Walma; Wouter Wieling
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

3.  [Significance of diagnostic methods in the work-up of syncope].

Authors:  C Strotmann; N Rüb; C Wolpert
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-06

4.  The implantable loop recorder: a tool that is "here to stay".

Authors:  Carel C Cock
Journal:  Indian Pacing Electrophysiol J       Date:  2002-01-01

5.  Implantable loop recorders: a novel method to judge patient perception of atrial fibrillation. Preliminary results from a pilot study.

Authors:  Annibale S Montenero; Abdul Quayyum; Pasquale Franciosa; Daniele Mangiameli; Andrea Antonelli; Luca Barbieri; Nicola Bruno; Francesco Zumbo; Marco Vimercati
Journal:  J Interv Card Electrophysiol       Date:  2004-06       Impact factor: 1.900

6.  Arrhythmia detection by patient and auto-activation in implantable loop recorders.

Authors:  Ernest Ng; Peter J Stafford; G André Ng
Journal:  J Interv Card Electrophysiol       Date:  2004-04       Impact factor: 1.900

7.  Use of implantable loop recorders to unravel the cause of unexplained syncope.

Authors:  Aniket Puri; Rohit Kumar Srivastava
Journal:  Indian Pacing Electrophysiol J       Date:  2013-03-07

8.  Discrepancy between clinical practice and standardized indications for an implantable loop recorder in patients with unexplained syncope.

Authors:  Elena Vitale; Andrea Ungar; Roberto Maggi; Maura Francese; Maurizio Lunati; Roberto Colaceci; Attilio Del Rosso; Antonio Castro; Massimo Santini; Silvia Giuli; Lara Belgini; Ivo Casagranda; Michele Brignole
Journal:  Europace       Date:  2010-10       Impact factor: 5.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.